splicing process, however, had not been investigated.
). We set out to investigate the molecuterminal glycine-rich region of SXL has been implicated in cooperative RNA binding and shown to be important lar basis for these observations. No splicing of transcripts spanning Sxl exons 2-4 with for autoregulation (Wang and Bell, 1994 ).
Here we report that, in contrast to regulatory mechaeither Drosophila or human nuclear extracts under a variety of experimental conditions was detected. This nisms described so far, SXL inhibits the last step of the splicing process. SXL accomplishes this by interacting was also the case for deleted transcripts lacking segments of introns 2 and/or 3 (data not shown). Therefore, through its amino-terminal domain with SPF45. a chimeric RNA (A3S) was generated where the 3Ј end of an Adenovirus (AdML) intron was substituted by the Results corresponding region of Sxl intron 2 (including both proximal and distal 3Ј ss). Incubation of A3S RNA under Sex-lethal (SXL) protein promotes skipping of exon 3 from its own pre-mRNA ( Figure 1A ). Three other features of this 3Ј ss region observed in vivo were also recapitulated in vitro using suggesting that recognition of the distal 3Ј sspresumably by U2AF 35 ( Figure 2B )-is important for recthe A3S substrate. First, the distal site was utilized upon mutation of the proximal 3Ј ss AG (compare lanes 4 and ognition of the proximal 3Ј ss by the 45 kDa species. Two lines of evidence indicated that the 45 kDa spe-6; the use of the distal site was confirmed by sequencing of the product). Second, mutation of either the distal AG cies was the spliceosomal protein SPF45. First, the 45 kDa species crosslinked to the proximal AG was effior its associated Py-tract resulted in general inhibition of splicing (lanes 8 and 10). Third, consistent with the idea ciently and specifically immunoprecipitated by antibodies that recognize either a peptide region of SPF45 or that the distal 3Ј ss region is important for early events involved in spliceosome assembly, both mutation of the the complete protein ( Figure 2D , left, compare lanes 1 and 7 with lanes 4 and 10, and data not shown). As Py-tract and mutation of the distal 3Ј ss AG resulted in reduction of prespliceosomal complex A formation observed for the 45 kDa crosslinking product, mutation of either the proximal or the distal 3Ј ss reduced SPF45 ( Figure 1C , compare lanes 4 with 8 and 10). We conclude that in vitro splicing of the A3S RNA in HeLa nuclear crosslinking ( Figure 2D , left, compare lane 1 with lanes 2 and 3). Second, purified recombinant His-tagged SPF45 extracts recapitulates characteristic properties of this unusual arrangement of 3Ј ss as observed for Sxl exon added to nuclear extracts crosslinked to the RNA specifically labeled at the proximal AG, but not to a mutant 3 in vivo.
derivative in which the AG was mutated to CA, and was precipitated by nickel-agarose beads ( Figure 2D , right, Proteins that Interact with P and D 3 ss lanes 1 and 2 1 and 2) . Taken toinduced complete skipping of exon 3 in cells that had been treated with control dsRNA ( Figure 3A, lanes 1-4) Figure 2C, lane 1) . Several results attributed to SPF45 expression because efficient regulation by SXL was restored by overexpression of human suggested that this species was relevant to the switch in 3Ј ss utilization associated with exon 3 splicing and SPF45 in these cells (lanes 9-12). The nucleotide sequence of human and Drosophila SPF45 is sufficiently its regulation. First, crosslinking was specific because it was abolished by mutation of the proximal AG to CA different so that Drosophila SPF45 dsRNA does not interfere with human SPF45 expression. The effects ob-(A3S-mutP, lane 2). Second, crosslinking was reduced by mutation of the distal 3Ј ss AG (A3S-mutD, lane 3), served were not due to changes in the expression of To test whether interference with SPF45 function influ-
SPF45 Is a Second Step Factor
To analyze the function of SPF45, HeLa nuclear extracts enced the relative use of the proximal and distal sites, RT-PCR assays were carried out using primers designed were immunodepleted of this factor and their splicing activity was analyzed. Immunodepletion reduced the to distinguish between products generated by the use of each of the splice sites (Penalva et al., 2001 ). While levels of SPF45 to less than 10% of mock-depleted extracts ( Figure 4A ). Splicing assays showed that deplethe proximal site is preferentially used in control cells (as previously reported, Penalva et al., 2001), the distal tion with preimmune serum resulted in a relative increase in the use of the distal site and accumulation site is preferentially used in cells transfected with SPF45 dsRNA ( Figure 3C, compare lanes 1 and 2) . Overexpresof the corresponding lariat product (compare lane 2 in Figure 4B with lane 4 in Figure 1B ). These effects may, sion of hSPF45 increased the use of the proximal site (lane 3), arguing that the effects on 3Ј ss utilization were however, be related to nonspecific (e.g., dilution) effects of the depletion procedure, because splicing assays specifically related to SPF45 activity. These observations suggest that SPF45 activity correlates with the use carried out with nuclear extract preparations differing in overall protein concentration also resulted in different of the proximal site.
Based on the interaction data presented in the previdegrees of distal site utilization (data not shown). SPF45 depletion resulted in reduced levels of spliced mRNAs ous section and the observation that interference with SPF45 function has effects similar to those of mutation and lariat products, and a concomitant increase in the levels of intermediates generated by the first step of requires binding sites for the protein within the premRNA. However, addition of SXL to splicing reactions splicing ( Figure 4B ). These effects could be partially reversed by addition of recombinant purified hSPF45 to containing A3SU RNA caused inhibition of the second step of splicing and accumulation of the first exon and the depleted extracts (compare lanes 3 and 4). SPF45 depletion affected utilization of the proximal but not the lariat intermediate ( Figure 5B , compare lanes 2 and 3). Importantly, SXL had no effect on splicing of the A3SU-distal 3Ј ss. Moreover, SPF45 depletion had little or no effect on splicing of the mutant A3S-mutP RNA, in which mutP RNA, which contains SXL binding sites but lacks the proximal 3Ј ss ( Figure 5B, compare lanes 6 and 7) . the proximal site was mutated from AG to CA (A3S-mutP) ( Figure 4C ). Together, these findings suggest that This suggests that the A3SU RNA was made refractory to SXL inhibition by preventing recognition of the proxithe proximal and distal 3Ј ss show different requirements for SPF45. mal 3Ј ss by SPF45. We conclude that SXL inhibits A3SU splicing at a late step in the splicing process and that inhibition requires SXL Inhibits A3S Splicing at the Second activation of the proximal 3Ј ss by SPF45.
Catalytic
Step To investigate the possibility that SXL regulates selection of the 3Ј ss at a step related to SPF45 activity, a
Mechanism of Regulation
To test whether SXL inhibited the association of SPF45 derivative of A3S RNA was generated in which a wellcharacterized SXL binding site (Handa et al., 1999) was with the proximal 3Ј ss, crosslinking and immunoprecipitation experiments were carried out essentially as in introduced both upstream and downstream of the 3Ј ss region (Figure 5A, A3SU) . This RNA maintained both the Figure 2D . The results indicate that inhibition of A3SU splicing by SXL was not related to a block of SPF45 preferential use of the proximal 3Ј ss ( Figure 5B , lane 2), as well as the activation of the distal 3Ј ss upon interaction with the pre-mRNA ( Figure 5C , compare lanes 1 and 2). Next we considered the possibility that mutation of the proximal site ( Figure 5B, lane 6) . SXL had no effect on A3S splicing (data not shown), consis-SXL and SPF45 interact directly with each other. In vitro translated SPF45 was coprecipitated with recombinant tent with the expectation that splicing regulation by SXL 6 and 13 and 14) , indicating that SXL and therefore in an mRNA that cannot code for globin, thus giving rise to the ␤-thalassemic condition. Previous work SPF45 interact through their amino termini.
Previous work has shown that the amino-terminal doindicated that activation of the cryptic site was dependent upon the integrity of the natural 3Ј ss (Krainer et main of SXL is important for Sxl autoregulation in vivo (Wang and Bell, 1994). Guided by these in vivo results
al., 1985; Zhuang and Weiner, 1990), similar to the dependence on the distal site for proximal site activation and by the interaction between SXL and SPF45 described above, the activity of a SXL derivative lacking in Sxl exon 3. Given the similarities between the two systems, we hypothesized that SPF45 could be involved the 94 amino-terminal amino acids was tested in in vitro splicing assays. This mutant was unable to inhibit the in activation of the ␤ 110 cryptic 3Ј ss. To test this possibility, we made use of the cell culture system described second step of A3SU RNA splicing ( Figure 5B, lane 4 4 with lanes 5-7) . These results establish a correlation between the ability of SXL to interact with SPF45 normal and cryptic 3Ј ss was determined by RT-PCR using primers designed to allow discrimination between and its ability to inhibit the second catalytic step. Taken together, the data are consistent with a model in which the use of each of the sites. The natural 3Ј ss was used in cells transfected with the wild-type minigene and control SXL inhibits splicing of SPF45-dependent substrates by Taken together, the results suggest a common molection of SPF45 during the second catalytic step can be inhibited by binding to SXL, thereby providing an unanular basis for the switch in 3Ј ss utilization observed in Sxl exon 3 and for the activation of a cryptic 3Ј ss in ticipated mechanism for regulation of splice site utilization. ␤-globin by the ␤ 110 mutation. In both cases, SPF45 plays a role in the utilization of an upstream 3Ј ss AG. Figures 3C and 6) . We efficient to keep a tight control over sex identity and viability. This may impose, however, serious mechaniscannot completely rule out, however, that more extensive in vivo or in vitro depletion than achievable using tic problems to regulators attempting to interfere with early steps of spliceosome assembly. Inhibition of the the currently available reagents would not reveal a more general requirement for SPF45 in splicing. second catalytic step may allow SXL to effectively promote skipping of exon 3 after it has been recognized as an exon but before it is included in the spliced prod-SPF45 and Sxl Autoregulation uct. Dual recognition of the 3Ј ss and dependence on ing possibility that SPF45 could be used as a therapeutic SXL does not prevent SPF45 from binding to the proxitarget for treating at least one class of ␤-thalassemias. mal 3Ј ss. Instead, the two proteins interact through Finally, these results strongly suggest that the mechatheir N termini. In this way, SXL inhibits SPF45 function nism of cryptic splice site activation is likely to be similar ( Figure 7D ). As the distal site is not activated in the to that observed for the activation of the proximal 3Ј ss presence of SXL, SPF45 bound to SXL is still capable in Sxl exon 3, implying a more general role for SPF45 of selecting the proximal over the distal site, but fails in splicing control. to activate it for catalysis. These observations, therefore, suggest three distinct functions for SPF45: specific recognition of the proximal 3Ј ss, commitment of this site Homology searches in FlyBase identified the Drosophila melanoses were as described previously (Penalva et al., 2001 ). RNA interference was achieved using 6 g/ml of double-stranded RNA gaster gene AE002927 as the putative homolog of SPF45. dSPF45 cDNA was obtained by cloning a product of PCR amplification from generated by in vitro transcription using T7 RNA polymerase and PCR-generated templates containing T7 promoters at both ends of an embryo stage V cDNA library (Clontech) using oligonucleotides corresponding to the 5Ј and 3Ј ends of SPF45 ORF.
SPF45 Is a Second Step Splicing Factor
the sequences corresponding to GFP (entire ORF, 717 bp) or SPF45 (ORF nucleotides 1-605). The products of transcription were heated Antibodies were raised (EUROGENTECH, Belgium) in rabbits against a peptide with the sequence NH2-CPYEEDSRPRSQSSKAat 65ЊC for 30 min and kept at room temperature for 1 hr before addition to the cultures at the time of Lipofectin-mediated trans-COOH coupled to keyhole limpet hemacyanine or in sheep against the full-length protein (Scottish Antibody Production Unit).
fection.
ss Usage Analyses Splicing Substrates and Reporters
We analyzed 15 g of total RNA from cells transfected with pRmHa-A3S was generated by replacing the sequence CAUACUUAUCCU 234 or pRmHA-␤/␤ 110 globin plasmids by RT-PCR using the following GUCCCUUUUUUUUCCACAG from the intron 1 of adenovirus major primer pairs: GGTTGCTTTGCGTTACAAAAA (antisense exon 3) and late transcripts in plasmid pMINX (Zillmann et al., 1988) by the se-AATAATAATGGTGGTTATCC (sense exon 2) for Sxl RNAs; TCCAGG quence of Sxl intron 2 indicated in Figure 1A . Mutant derivatives GTAGACCACCAG (antisense exon 2) and TGCACCTGACTCCT were generated from this construct by PCR-based site-directed GAGGA (sense exon 1) for ␤-globin RNAs. PCR reactions were ammutagenesis and confirmed by sequencing. pRmHA-TE234 and plified for 25 cycles of 1 min at 94ЊC, 1 min at 60ЊC, and 30 s at pRmHA-SXL were described in Penalva et al. (2001) . pRmHa-␤ glo-72ЊC, followed by a final extension of 10 min at 72ЊC. The products bin and pRmHa-␤ 110 were generated by cloning a fragment of ␤ of amplification were analyzed by electrophoresis on nondenaturing globin (or its ␤-thalassemic variant ␤ 110 ) first intron and flanking 6% polyacrylamide gels. exons into the copper-inducible expression plasmid pRmHA.
